Sort
261,768 grants matching “gene therapy”
COMPREHENSIVE SICKLE CELL CENTER
$1,296,019University Of Southern California · P60 · FY2001 · HL
Oxidative Stress, AMPK &Diabetic Cardiovascular Disease
$1,295,891Boston Medical Center · P01 · FY2004 · HL
Infections and The Stability of Transplantation Tolerance
$1,295,861Anita S. Chong · University Of Chicago · P01 · FY2015 · AI
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
$1,295,829James Wilson · University Of Pennsylvania · N01 · FY2016 · HL
Perivascular plasticity in metastatic microenvironments
$1,295,670Meera Murgai · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations
$1,295,529Anne M Connolly · Research Inst Nationwide Children'S Hosp · U01 · FY2023 · NS
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis
$1,295,444Douglas A Marchuk · Duke University · P01 · FY2023 · NS
Psychobiology and Treatment of Perimenopausal Mood Disorders
$1,295,417Peter Schmidt · National Institute Of Mental Health · ZIA · FY2024 · MH
Development of Oncomine Professional as a Platform for Biopharmaceutical Research
$1,295,397Daniel R Rhodes · Compendia Bioscience, Inc. · R44 · FY2008 · CA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,295,221Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$1,295,181Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Biology of memory
$1,295,000Ronald L Davis · University Of Florida · R35 · FY2023 · NS
GENE THERAPY FOR ALZHEIMERS DISEASE
$1,294,880Salk Institute For Biological Studies · P01 · FY2000 · AG
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,294,431Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2022 · AI
Novel model systems for the study of cone disorders and other heritable retinal diseases
$1,294,245Jeffrey A Rogers · Baylor College Of Medicine · U24 · FY2022 · EY
SORT1:PGRN blocking antibodies for Frontotemporal dementia
$1,294,191Arnon Rosenthal · Alector, Llc · R44 · FY2016 · AG
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
$1,293,876Rafick-Pierre Sekaly · Emory University · P01 · FY2023 · AI
GENE THERAPY FOR MALIGNANT MESOTHELIOMA
$1,293,872University Of Pennsylvania · P01 · FY2001 · CA
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$1,293,832Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
RNAi for Dominant Neurological Disease
$1,293,698Beverly L Davidson · University Of Iowa · P01 · FY2009 · NS
From Structure to Therapy: The TRiC Chaperonin Network in Huntington's Disease
$1,293,620Leslie Michels Thompson · University Of California-Irvine · P01 · FY2019 · NS
Immunotherapy to deplete key Treg subsets in solid tumors
$1,293,505Peter David Suzdak · Sonoval Llc · R44 · FY2024 · CA
Minimally Invasive Local Delivery of Cardiac Gene Therapy
$1,293,419Esra Roan · Corami Biotech Inc. · R42 · FY2025 · HL
Mechanism, Regulation and Application of miRNA pathway in cancer
$1,293,233Shuo Gu · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
The Two Sister Study
$1,293,228Clarice Weinberg · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES